The treatment with little-moderate doses decreased TSH significantly and TSH suppression mild to strong was achieved in a half of treated investigative; furthermore, the size of thyroid nodules have changed statistically significant after 6 months of therapy and positive effect was reached for 89.2% of treated patients.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/12474656